| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunome, Inc. (IMNM) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. IMNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 360.0K | $9.30M | - | |
| Dir | 341.1K | $8.81M | - | |
| Dir | 108.5K | $2.80M | - | |
| CFO | 94.5K | $2.44M | - | |
| Other | 76.5K | $1.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Tsai Philip76 | Chief Technical Officer | Buy | 10,000 | $20.49 | $204,900.00 | +30.0% | -2.8% | - | |
| Dec 18, 2025 | Siegall Clay B77 | President And CEO | Buy | 46,511 | $21.50 | $999,986.50 | +5.8% | +3.4% | - | |
| Jun 3, 2025 | Bienaime Jean Jacques68 | Director | Buy | 5,000 | $9.38 | $46,900.00 | +15.9% | +0.2% | +135.7% | |
| Mar 26, 2025 | Siegall Clay B77 | President And CEO | Buy | 137,100 | $7.29 | $999,459.00 | +20.5% | +25.8% | +187.9% | |
| Mar 25, 2025 | Bienaime Jean Jacques68 | Director | Buy | 7,800 | $7.78 | $60,684.00 | +33.0% | +25.8% | +192.1% | |
| Mar 24, 2025 | Bienaime Jean Jacques68 | Director | Buy | 7,000 | $8.21 | $57,470.00 | +42.1% | +7.2% | +148.0% | |
| Mar 24, 2025 | Tsai Philip76 | Chief Technology Officer | Buy | 12,300 | $8.42 | $103,566.00 | +58.6% | +7.2% | +148.0% | |
| Jan 31, 2025 | Siegall Clay B77 | President And CEO | Buy | 150,000 | $7.75 | $1,162,500.00 | +28.9% | -19.7% | +123.2% | |
| Nov 22, 2024 | Siegall Clay B77 | President And CEO | Buy | 100,000 | $9.62 | $962,181.46 | +11.0% | +3.0% | +88.7% | |
| Nov 21, 2024 | Lechleider Robert | Chief Medical Officer | Buy | 15,805 | $9.48 | $149,799.79 | New | +5.1% | +96.7% |